Form 4/A for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2024-09-16 00:00:00 ET · period of report 2024-08-19 · accession 0001628280-24-040456 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-09-16 | 2024-08-19 | LFCR | Antunes Humberto Calheiros | Dir | A - Grant | — | +24.6K | 27.6K | +818% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-19 | A | A | 24,554 | — | 27,554 | D | — | — | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. (F2) Vests on earlier of July 8, 2025 or the date of the annual meeting of stockholders of the Company first held in calendar year 2025 (provided such date is no less than 50 weeks from July 8, 2024). (F3) Amendment includes 3,000 shares that were inadvertently omitted from the Form 3 filed on behalf of the reporting person on August 21, 2024. |